Toxicology Stocks List Ranked for 2024 | NYSE,

Symbol	Grade	Name	% Change
BLFS	B	BioLife Solutions, Inc.	2.04
INM	B	InMed Pharmaceuticals Inc.	6.38
NEOG	D	Neogen Corporation	-0.40
CRL	D	Charles River Laboratories International, Inc.	2.87
EXPO	D	Exponent, Inc.	1.32
HBIO	F	Harvard Bioscience, Inc.	0.23
SAGE	F	Sage Therapeutics, Inc.	-1.73
EGRX	F	Eagle Pharmaceuticals, Inc.	0.00
OSUR	F	OraSure Technologies, Inc.	1.57
ATHE	F	Alterity Therapeutics Limited	2.70

Symbol	Grade	Name	Weight
PSIL	C	AdvisorShares Psychedelics ETF	4.78
AWEG	B	Alger Weatherbie Enduring Growth ETF	3.62
IVEG	C	iShares Emergent Food and AgTech Multisector ETF	2.59
FTXH	D	First Trust Nasdaq Pharmaceuticals ETF	2.47
HELX	D	Franklin Genomic Advancements ETF	2.23

Compare ETFs

Date	Stock	Title
Nov 21	SAGE	Sage ends dalzanemdor development following Phase II trial failure
Nov 21	SAGE	SAGE's Dalzanemdor Fails to Meet Goal in Huntington's Disease Study
Nov 21	SAGE	Sage raised to sector perform by RBC in wake of drug failure
Nov 20	SAGE	After Failed Alzheimer's Study, Sage Therapeutics' Dalzanemdor Flunks Another Study In Patients With Inherited Brain Disorder
Nov 20	SAGE	Sage slips as Huntington’s Disease therapy fails in mid-stage trial
Nov 20	SAGE	Sage’s string of research failures continues
Nov 20	SAGE	Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington’s Disease
Nov 19	SAGE	CNS Drug Development: Same As It Ever Was
Nov 19	CRL	Charles River Laboratories: Not The Right Time To Own At This Point In The Cycle
Nov 18	OSUR	OraSure to Participate in Upcoming Investor Conference
Nov 15	EGRX	Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration
Nov 15	BLFS	BioLife Solutions, Inc. (NASDAQ:BLFS) Just Reported And Analysts Have Been Cutting Their Estimates
Nov 14	NEOG	Neogen Chemicals Ltd (BOM:542665) Q2 2025 Earnings Call Highlights: Strong Revenue Growth ...
Nov 14	CRL	Eminence Capital buys Gitlab, Charles River, exits Haleon, others in Q3
Nov 14	BLFS	BioLife Solutions sells its Custom Biogenic Systems freezer subsidiary for $6.1M
Nov 14	BLFS	BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary

Toxicology: Toxicology is a discipline, overlapping with biology, chemistry, pharmacology, and medicine, that involves the study of the adverse effects of chemical substances on living organisms and the practice of diagnosing and treating exposures to toxins and toxicants. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Factors that influence chemical toxicity include the dosage (and whether it is acute or chronic), route of exposure, species, age, sex, and environment. Toxicologists are experts on poisons and poisoning.